Evaluating the use of transesophageal echocardiography in critically-ill patients
Evaluation of the Clinical Impact and Safety of Focused Transesophageal Echocardiography During Resuscitation of Critically Ill Patients in the Emergency Department and Intensive Care Settings
This study tests how using a special heart ultrasound called transesophageal echocardiography can help critically-ill patients in emergency and intensive care settings.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Pennsylvania Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Trial ID | NCT04972526 on ClinicalTrials.gov |
What this trial studies
This study evaluates the clinical impact and safety of focused, point-of-care transesophageal echocardiography (TEE) in critically-ill patients receiving care in emergency and intensive care settings. It aims to characterize the use of TEE in patients experiencing shock and cardiac arrest, including the frequency of studies, clinical indications, and patient outcomes. The registry facilitates collaboration among clinical teams and standardizes data collection to enhance research in this area.
Who should consider this trial
Good fit: Ideal candidates include adult critically-ill patients over 18 who are receiving focused TEE as part of their routine clinical care.
Not a fit: Patients under 18 years old or those considered vulnerable populations may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the management and outcomes of critically-ill patients undergoing resuscitation.
How similar studies have performed: Other studies have shown promise in using point-of-care ultrasound techniques in critical care, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult critically-ill patients who as part of their routine clinical care receive focused TEE in the emergency department of intensive care setting. Exclusion Criteria: * Children (age under 18 years) * Vulnerable populations
Where this trial is running
Philadelphia, Pennsylvania
- University of Pennsylvania — Philadelphia, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Felipe Teran, MD, MSCE — Weill Medical College of Cornell University
- Study coordinator: Caleb Suh
- Email: cts95@cornell.edu
- Phone: 5715674373
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.